Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 17, 2020Cancer Treatment ReviewsOpen Access

How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement

View Full Paper
Ask AI
Bookmark
Share

Authors

INIrıs D. NagtegaalRGRob Glynne‐Jones

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nagtegaal et al. (2020) studied this question.

synapsesocial.com/papers/6aaa3fc835c9841531c1fa5ehttps://doi.org/10.1016/j.ctrv.2020.101964
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8‐year retrospective single‐institutional study2017 · 20 citations
  2. 2MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer2019 · 139 citations
  3. 3Prevalence and Clinical Significance of Acellular Mucin in Locally Advanced Rectal Cancer Patients Showing Pathologic Complete Response to Preoperative Chemoradiotherapy2012 · 39 citations
  4. 4What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?2008 · 1,017 citations